Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke

This study was designed to investigate the impact of the preexisting use of beta-blockers, angiotensin-converting enzyme inhibitors (ACEIs), or angiotensin receptor blockers (ARBs) on the cellular immune response in peripheral blood and the clinical outcomes of patients with acute ischemic stroke. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yuanyuan, Nie, Kelin, Wallace, Kevin L., Li, Fangfang, Zhang, Jing, Li, Caizhen, Wang, Yingying, Zhang, Jiewen, Wang, Jian, Jiang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908343/
https://www.ncbi.nlm.nih.gov/pubmed/36778208
http://dx.doi.org/10.1155/2023/7733857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908343/
https://www.ncbi.nlm.nih.gov/pubmed/36778208
http://dx.doi.org/10.1155/2023/7733857

Ejemplares similares